Essential Documents for the Conduct of a Clinical Trial are intended to permit evaluation of which aspects?

Essential Documents for the Conduct of a Clinical Trial are intended to permit evaluation of which aspects?

• A. The conduct of the trial and the quality of the data produced
• B. Regulatory submissions only
• C. Sponsor marketing plans
• D. Participant recruitment numbers only

Answer: (A)

Essential documents are the records kept so regulators and monitors can verify that the trial was conducted in accordance with the protocol, GCP, and applicable regulations, and that the data generated are credible. Their purpose is to permit evaluation of how the trial was run and the quality and integrity of the data produced. These documents cover items such as approvals, informed consent, protocol and amendments, monitoring and audit reports, and data handling processes, among others. They support regulatory review, but their scope goes beyond submissions or any single aspect like recruitment or marketing plans. Recruitment numbers alone don’t show compliance or data quality, and marketing plans are not part of documenting trial conduct or data integrity.

Essential documents are the records kept so regulators and monitors can verify that the trial was conducted in accordance with the protocol, GCP, and applicable regulations, and that the data generated are credible. Their purpose is to permit evaluation of how the trial was run and the quality and integrity of the data produced. These documents cover items such as approvals, informed consent, protocol and amendments, monitoring and audit reports, and data handling processes, among others. They support regulatory review, but their scope goes beyond submissions or any single aspect like recruitment or marketing plans. Recruitment numbers alone don’t show compliance or data quality, and marketing plans are not part of documenting trial conduct or data integrity.